About Us

Our Science

Our Proprietary RNAi Drug Discovery Platform, LEAD™,
Enable Us to Efficiently Develop Innovative RNAi Therapeutics
Advanced and Novel Hepatic Delivery Platform
Our proprietary LEAD™ GalNAc platform enables safe, efficient and precise delivery of RNAi drugs to liver tissue, at an international leading level
Groundbreaking Extrahepatic Delivery Platform
We have put great emphasis on the development of LEAD™ platform for extrahepatic delivery, extending the reach of RNAi medicines beyond hepatic tissues

Our Pipeline

Advancing RNAi Therapeutics Development
Through Innovation to Fill Unmet Clinical Needs
Our Fast-Growing RNAi Portfolio Covers a Broad Range of Therapeutic Areas
Including Cardiovascular and Metabolic Diseases, Immunology-Related Diseases, and Nervous System Diseases

News

  • Home
  • Phone
  • Top